Common specification requirements for in vitro diagnostic devices
Read the full outcome
Detail of outcome
This document analyses the responses to the public consultation on the proposed amendments to the Medical Devices Regulations 2002 regarding the Common Specifications requirements for certain high-risk in vitro diagnostic devices (IVD devices), including COVID-19 tests and the COVID-19 Test Device Approvals (CTDA) process.
The consultation ran from 20 May to 14 June 2024 and received 39 responses from various stakeholders, such as IVD device suppliers and producers, healthcare professionals, trade associations, individuals, and patient groups.
Original consultation
Consultation description
MHRA is inviting members of the public, including the patients, medical device researchers, developers, manufacturers and suppliers, clinicians, other healthcare professionals to provide their views on the introduction of common specification requirements to the regulatory framework before IVD devices can be placed on the GB market. We are also seeking views on the removal of the Coronavirus Test Device Approval (CTDA) process to avoid duplication of regulatory requirements for COVID-19 tests against the Common Specification requirements.